Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f7b665fb8f15d0e2b0911539d39f8a2 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
filingDate |
2006-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2010-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d95b57d0271148fd6ec0f58c4fbc433 |
publicationDate |
2010-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2334319-B1 |
titleOfInvention |
ANTAGONISTS OR INVESTED AGONISTS OF CB1 AS THERAPEUTIC AGENTS FOR THE TREATMENT OF INFLAMMATION IN WHICH THE GENICAL EXPRESSION PARTICIPATES. |
abstract |
CB1 antagonists or inverse agonists such asntherapeutic agents for the treatment of inflammation in thenthat gene expression participates.n n n The present invention relates to compounds ofnsubstituted pyrazoline, preparation procedures,nmedicines comprising these compounds, as well as their use fornthe preparation of a medicine for the treatment of beingsnhumans and animals |
priorityDate |
2005-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |